November 14, 2019

China’s BeiGene Gets FDA Approval for Drug to Treat Rare Form of Lymphoma

(Reuters) – The U.S. Food and Drug Administration on Thursday approved BeiGene Ltd’s lymphoma treatment, validating the China-based drugmaker’s strategy of largely using data from trials held outside the United States to file for approval. The company tested the treatment, … Read More

November 14, 2019

The First US Clinical Trial of Using an In-Brain Chip to Fight Opioid Addiction Is Now Underway

(Tech Crunch) – Opioid addiction is easily one of the top widespread healthcare issues facing the U.S., and research indicates we’re nowhere near achieving any kind of significant mitigating solution. But a team of medical researchers working at the West … Read More

Recommended Reading